Management of Immune-Related Adverse Events in Patients Treated with Immune Oncology Agents: Role of Emergency Physicians in the Multidisciplinary Team

 

Please join us for a Virtual Reality CME Meeting in conjunction with the 2017 Annual Scientific Assembly of ACEP

 
MONDAY, OCTOBER 30, 2017
6:30 AM – 8:00 AM

Location

Washington DC Marriott Marquis
901 Massachusetts Ave NW
Washington, DC 20001
Meeting room: Salon 3/4

 

REGISTER NOW!
Already Registered?
SIGN IN

 
 

WEBCAST DATE

MONDAY, OCTOBER 30, 2017

6:30 AM Eastern    5:30 AM Central    4:30 AM Mountain    3:30 AM Pacific

Add to Calendar 10/30/2017 06:30 AM 10/30/2017 08:00 AM America/New_York Management of Immune-Related Adverse Events in Patients Treated with Immune Oncology Agents: Role of Emergency Physicians in the Multidisciplinary Team Management of Immune-Related Adverse Events in Patients Treated with Immune Oncology Agents: Role of Emergency Physicians in the Multidisciplinary Team Live Simulcast Med Learning Group info@medlearninggroup.com false MM/DD/YYYY atZOdzeAgzXtBkKLjmOo27579

 

PROGRAM FEATURES

  • Case-based learning environment
  • Ipads provided to enhance learning environment
  • Virtual Reality videos included in presentation

Faculty

Arjun B. Balar, MD
Assistant Professor, Department of Medicine
Director, Genitourinary Medical Oncology Program
NYU Langone Medical Center
New York, NY

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:
• Critically evaluate clinical data of emerging PD-1/PD-L1 inhibitors, with a focus on the unique type, incidence, classification and organ distribution of immune-related adverse events (irAEs)
• Describe how to reach a diagnosis of immune related adverse events due to immuneoncology agents and current recommendations for their management
• Discuss the role of emergency care physicians in the multidisciplinary recognition of the signs and symptoms of immune-related adverse events and their management

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Purpose:

This program would be beneficial for nurses involved in the management of patients treated with Immune Oncology Agents.

2.0 ANCC Contact Hour(s)

Accreditation Statement:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 2.0 contact hour(s) of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

 

 

WEBCAST REGISTRATION

Please use the following form to register for this webcast. You will receive an email confirmation shortly after you complete the registration.

If you are unable to register online or do not receive your confirmation email after registering, please email us at support@performedia.com.

Registration Form


*Required field

WEBCAST SIGNIN

Please enter your registered email and click the Sign In button to watch the Live Simulcast.

If you are unable to sign in or watch the live simulcast, please email us at support@performedia.com.

 

 

 

Copyright © 2017 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.